Design, synthesis, and pharmacological e
✍
Martin Pettersson; Brian M. Campbell; Amy B. Dounay; David L. Gray; Longfei Xie;
📂
Article
📅
2011
🏛
Elsevier Science
🌐
English
⚖ 718 KB
Compounds with combined norepinephrine reuptake inhibitor (NRI) and serotonin 1A (5-HT 1A ) partial agonist pharmacology may offer a new therapeutic approach for treating symptoms of neuropsychiatric disorders including ADHD, depression, and anxiety. Herein we describe the design and optimization of